# A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring

> **NCT06660342** · — · RECRUITING · sponsor: **Phathom Pharmaceuticals, Inc.** · enrollment: 728 (estimated)

## Conditions studied

- Erosive Esophagitis
- Heartburn
- Symptomatic Non-erosive Gastroesophageal Reflux Disease
- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Vonoprazan

## Key facts

- **NCT ID:** NCT06660342
- **Lead sponsor:** Phathom Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-15
- **Primary completion:** 2034-09
- **Final completion:** 2034-09
- **Target enrollment:** 728 (ESTIMATED)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06660342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06660342, "A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT06660342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*